title: Adjuvant tamoxifen: how long before we know how long?
authors.affiliation: Cancer Research Council Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA.
authors.forename: D
authors.initials: D
authors.lastname: Rea
authors.forename: C
authors.initials: C
authors.lastname: Poole
authors.forename: R
authors.initials: R
authors.lastname: Gray
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008134:Long-Term Care; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D013629:Tamoxifen / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen